bis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol)

C112H102N24O9 — CID 157163680

IUPACbis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol)
SMILESCOc1cccc2[nH]c(-c3cccc(C)n3)nc12.COc1cccc2[nH]c(-c3cccc(C)n3)nc12.Cc1cccc(-c2nc3ccc(CO)cc3[nH]2)n1.Cc1cccc(-c2nc3ccc(CO)cc3[nH]2)n1.Cc1cccc(-c2nc3ccc(CO)cc3[nH]2)n1.Cc1cccc(-c2nc3ccc(CO)cc3[nH]2)n1.Cc1ccnc(-c2nc3ccc(CO)cc3[nH]2)c1.Cc1ccnc(-c2nc3ccc(OC=O)cc3[nH]2)c1
InChIInChI=1S/C14H11N3O2.7C14H13N3O/c1-9-4-5-15-13(6-9)14-16-11-3-2-10(19-8-18)7-12(11)17-14;2*1-9-5-3-7-11(15-9)14-16-10-6-4-8-12(18-2)13(10)17-14;1-9-4-5-15-13(6-9)14-16-11-3-2-10(8-18)7-12(11)17-14;4*1-9-3-2-4-12(15-9)14-16-11-6-5-10(8-18)7-13(11)17-14/h2-8H,1H3,(H,16,17);2*3-8H,1-2H3,(H,16,17);5*2-7,18H,8H2,1H3,(H,16,17)
InChIKeyAMQXGMKHYWGPPH-UHFFFAOYSA-N
MW1928.21 g/mol
LogP20.48
Rot. Bonds17

About bis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol)

bis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol) (PubChem CID 157163680) has the molecular formula C112H102N24O9 and a molecular weight of 1928.21 g/mol. Its IUPAC name is bis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol).

Molecular Properties

Compound Namebis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol)
PubChem CID157163680
Molecular FormulaC112H102N24O9
Molecular Weight1928.21 g/mol
Exact Mass1926.83
IUPAC Namebis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol)
SMILESCOc1cccc2[nH]c(-c3cccc(C)n3)nc12.COc1cccc2[nH]c(-c3cccc(C)n3)nc12.Cc1cccc(-c2nc3ccc(CO)cc3[nH]2)n1.Cc1cccc(-c2nc3ccc(CO)cc3[nH]2)n1.Cc1cccc(-c2nc3ccc(CO)cc3[nH]2)n1.Cc1cccc(-c2nc3ccc(CO)cc3[nH]2)n1.Cc1ccnc(-c2nc3ccc(CO)cc3[nH]2)c1.Cc1ccnc(-c2nc3ccc(OC=O)cc3[nH]2)c1
InChIInChI=1S/C14H11N3O2.7C14H13N3O/c1-9-4-5-15-13(6-9)14-16-11-3-2-10(19-8-18)7-12(11)17-14;2*1-9-5-3-7-11(15-9)14-16-10-6-4-8-12(18-2)13(10)17-14;1-9-4-5-15-13(6-9)14-16-11-3-2-10(8-18)7-12(11)17-14;4*1-9-3-2-4-12(15-9)14-16-11-6-5-10(8-18)7-13(11)17-14/h2-8H,1H3,(H,16,17);2*3-8H,1-2H3,(H,16,17);5*2-7,18H,8H2,1H3,(H,16,17)
InChIKeyAMQXGMKHYWGPPH-UHFFFAOYSA-N
XLogP20.48
TPSA478.47 Ų
H-Bond Donors13
H-Bond Acceptors25
Rotatable Bonds17
Heavy Atoms145
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001928.21
LogP ≤ 520.48
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1025

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze bis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of bis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol)?
The IUPAC name of bis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol) (CID 157163680) is bis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol).
What is the SMILES notation for bis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol)?
The canonical SMILES for bis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol) is COc1cccc2[nH]c(-c3cccc(C)n3)nc12.COc1cccc2[nH]c(-c3cccc(C)n3)nc12.Cc1cccc(-c2nc3ccc(CO)cc3[nH]2)n1.Cc1cccc(-c2nc3ccc(CO)cc3[nH]2)n1.Cc1cccc(-c2nc3ccc(CO)cc3[nH]2)n1.Cc1cccc(-c2nc3ccc(CO)cc3[nH]2)n1.Cc1ccnc(-c2nc3ccc(CO)cc3[nH]2)c1.Cc1ccnc(-c2nc3ccc(OC=O)cc3[nH]2)c1.
What is the InChIKey of bis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol)?
The InChIKey is AMQXGMKHYWGPPH-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H11N3O2.7C14H13N3O/c1-9-4-5-15-13(6-9)14-16-11-3-2-10(19-8-18)7-12(11)17-14;2*1-9-5-3-7-11(15-9)14-16-10-6-4-8-12(18-2)13(10)17-14;1-9-4-5-15-13(6-9)14-16-11-3-2-10(8-18)7-12(11)17-14;4*1-9-3-2-4-12(15-9)14-16-11-6-5-10(8-18)7-13(11)17-14/h2-8H,1H3,(H,16,17);2*3-8H,1-2H3,(H,16,17);5*2-7,18H,8H2,1H3,(H,16,17).
What are the key properties of bis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol)?
bis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol) has a molecular weight of 1928.21 g/mol, XLogP of 20.48, 17 rotatable bonds, 13 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for bis(4-methoxy-2-(6-methyl-2-pyridinyl)-1H-benzimidazole);[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl] formate;[2-(4-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol;tetrakis([2-(6-methyl-2-pyridinyl)-3H-benzimidazol-5-yl]methanol) is sourced from PubChem (CID 157163680), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).